Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2001 Dec;18(12):1660-8.
doi: 10.1023/a:1013358126640.

Comparative studies on in vitro methods for evaluating in vivo function of MDR1 P-glycoprotein

Affiliations
Comparative Study

Comparative studies on in vitro methods for evaluating in vivo function of MDR1 P-glycoprotein

Y Adachi et al. Pharm Res. 2001 Dec.

Abstract

Purpose: MDR1 P-glycoprotein (P-gp) plays an important role in determining drug disposition. The purpose of the present study was to establish in vitro models to predict the in vivo function of P-gp.

Methods: As an in vitro method, the transcellular transport of 12 compounds across the monolayer of Caco-2- and MDR1-transfected cells was examined. The ability of these compounds to stimulate the ATP hydrolysis was also determined using the isolated membrane fraction expressing P-gp. As a parameter to describe the in vivo P-gp function, we calculated the brain-to-plasma concentration ratio of compounds in mdr1a/1b knockout mice divided by the same ratio in wild type mice.

Results: A good correlation was observed between the in vitro flux ratio across the monolayer and in vivo P-gp function for 12 compounds. Although all compounds that stimulated ATP hydrolysis were significantly transported by P-gp, some compounds were transported by P-gp without significantly affecting ATP hydrolysis.

Conclusion: Collectively, the in vitro flux ratio across monolayers of P-gp-expressing cells may be used to predict in vivo P-gp function. The extent of ATP-hydrolysis in vitro may also be a useful parameter for in vivo prediction, particularly for eliminating P-gp substrates in high-throughput screening procedures.

PubMed Disclaimer

References

    1. J Clin Invest. 1997 Nov 15;100(10 ):2430-6 - PubMed
    1. J Clin Invest. 1996 Jun 1;97(11):2517-24 - PubMed
    1. J Biol Chem. 1996 Feb 9;271(6):3163-71 - PubMed
    1. J Pharmacol Exp Ther. 2001 Mar;296(3):723-35 - PubMed
    1. Br J Pharmacol. 1999 May;127(1):43-50 - PubMed

Publication types

Substances